While reporting financial results for the second quarter on Thursday, Abbott Laboratories (ABT) maintained its earnings and adjusted earnings guidance for the full-year 2021, which was slashed in early June due to significantly lower recent and projected COVID-19 diagnostic testing demand.
from RTT - Earnings https://ift.tt/3BrfYds
via IFTTT
No comments:
Post a Comment